There are several ways to beat the market, and investing in small cap stocks has historically been one of them. We like to improve the odds of beating the market further by examining what famous hedge fund operators such as Carl Icahn and George Soros think. Those hedge fund operators make billions of dollars each year by hiring the best and the brightest to do research on stocks, including small cap stocks that big brokerage houses simply don’t cover. Because of Carl Icahn and other elite funds’ exemplary historical records, we pay attention to their small cap picks. In this article, we use hedge fund filing data to analyze Mednax Inc. (NYSE:MD).
Is Mednax Inc. (NYSE:MD) a buy here? Money managers are taking a bullish view. The number of bullish hedge fund positions improved by 6 recently. At the end of this article we will also compare MD to other stocks, including Arthur J. Gallagher & Co. (NYSE:AJG), Synopsys, Inc. (NASDAQ:SNPS), and Mobil’nye Telesistemy PAO (ADR) (NYSE:MBT) to get a better sense of its popularity.
Follow Pediatrix Medical Group Inc. (NYSE:MD)
Follow Pediatrix Medical Group Inc. (NYSE:MD)
Today there are dozens of gauges investors have at their disposal to appraise publicly traded companies. A duo of the best gauges are hedge fund and insider trading interest. Our experts have shown that, historically, those who follow the best picks of the best investment managers can outclass their index-focused peers by a significant amount (see the details here).
Keeping this in mind, we’re going to take a look at the fresh action encompassing Mednax Inc. (NYSE:MD).
How have hedgies been trading Mednax Inc. (NYSE:MD)?
Heading into Q4, a total of 26 of the hedge funds tracked by Insider Monkey were bullish on this stock, a change of 30% from one quarter earlier. With the smart money’s sentiment swirling, there exists an “upper tier” of noteworthy hedge fund managers who were boosting their holdings substantially (or already accumulated large positions).
When looking at the institutional investors followed by Insider Monkey, Echo Street Capital Management, managed by Greg Poole, holds the number one position in Mednax Inc. (NYSE:MD). Echo Street Capital Management has a $22.9 million position in the stock, comprising 0.8% of its 13F portfolio. Coming in second is Israel Englander’s Millennium Management, with a $21.6 million position; the fund has less than 0.1%% of its 13F portfolio invested in the stock. Remaining peers that are bullish consist of Brian Ashford-Russell and Tim Woolley’s Polar Capital, Dmitry Balyasny’s Balyasny Asset Management and Ken Griffin’s Citadel Investment Group.
